mBio
A VLP-based mRNA vaccine elicits potent humoral and cellular immunity against Oropouche virus.
Yuren Shi, Guangxu Zhang, Siyu Lin, Mengyu Hu, Yuanzhou Wang, Haoyu Ge, Shuai Xia, Qian Wang, Shibo Jiang, Lu Lu
Published: 202610.1128/mbio.03653-25
Abstract
Oropouche virus (OROV) is reemerging in the Americas, along with a growing threat to global public health. Recent outbreaks have witnessed the first reported fatalities, vertical transmissions, and intercontinental importations of OROV, underscoring…
Preview only. Read the full abstract at the source